Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The closing price of NewAmsterdam Pharma Company NV (NASDAQ: NAMS) was $19.03 for the day, up 0.79% from the previous closing price of $18.88. In other words, the price has increased by $0.79 from its previous closing price. On the day, 0.53 million shares were traded.
Ratios:
Our analysis of NAMS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 19.98 and its Current Ratio is at 19.98. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on December 30, 2024, initiated with a Buy rating and assigned the stock a target price of $48.
On March 14, 2024, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $35.Scotiabank initiated its Sector Outperform rating on March 14, 2024, with a $35 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 15 ’25 when Douglas F Kling bought 298,612 shares for $18.75 per share.
NAP PoolCo B.V. bought 1,433,193 shares of NAMS for $21,669,878 on Apr 11 ’25. On Mar 26 ’25, another insider, Topper James N, who serves as the Director of the company, bought 1,135 shares for $22.49 each. As a result, the insider paid 25,521 and bolstered with 3,013,569 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 45.32 while its Price-to-Book (P/B) ratio in mrq is 2.75.
Stock Price History:
Over the past 52 weeks, NAMS has reached a high of $27.29, while it has fallen to a 52-week low of $14.06. The 50-Day Moving Average of the stock is -2.10%, while the 200-Day Moving Average is calculated to be -4.36%.
Shares Statistics:
A total of 112.17M shares are outstanding, with a floating share count of 62.27M. Insiders hold about 44.24% of the company’s shares, while institutions hold 57.52% stake in the company.
